Skip to main content

SPECIALTY GRAND CHALLENGE article

Front. Pharmacol.
Sec. Drugs Outcomes Research and Policies
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1476849

Drug Outcomes Research and Policies – Trends and Challenges

Provisionally accepted
Bernd Rosenkranz Bernd Rosenkranz 1,2,3*
  • 1 Medicine - Pharmacology, Fundisa African Academy of Medicines Development, Cape Town, South Africa
  • 2 Institute for Clinical Pharmacology and Toxicology, Charité University Medicine Berlin, Berlin, Baden-Württemberg, Germany
  • 3 Division of Clinical Pharmacology, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa

The final, formatted version of the article will be published soon.

    Keywords: outcomes research, Pharmaceutical policies, Effectiveness trials, Health Technology Assessment, patient-reported outcomes, healthcare delivery, Equity

    Received: 06 Aug 2024; Accepted: 14 Aug 2024.

    Copyright: © 2024 Rosenkranz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Bernd Rosenkranz, Medicine - Pharmacology, Fundisa African Academy of Medicines Development, Cape Town, 7505, South Africa

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.